COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

Abstract

The coronavirus disease-2019 (COVID-19) pandemic continues to be a cause of unprecedented global morbidity and mortality. Whilst COVID-19 vaccination has emerged as the only tangible solution to reducing poor clinical outcomes, vaccine hesitancy continues to be an obstacle to achieving high levels of vaccine uptake. This represents particular risk to patients with autoimmune diseases, a group already at increased risk of hospitalization and poor clinical outcomes related to COVID-19 infection. Whilst there is a paucity of long-term safety and efficacy data of COVID-19 vaccination in patients with autoimmune diseases, the current evidence strongly suggests that the benefits of vaccination outweigh the risks of adverse effects and disease flares. Herein, we report the protocol of the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study, an ongoing international collaborative study involving 29 countries and over 110 investigators.

Metadata

Item Type:	Article
Authors/Creators:	Sen, P Gupta, L Lilleker, JB Aggarwal, V Kardes, S Milchert, M Gheita, T Salim, B Velikova, T Gracia-Ramos, AE Parodis, I O’Callaghan, AS Nikiphorou, E Tan, AL https://orcid.org/0000-0002-9158-7243 Cavagna, L Saavedra, MA Shinjo, SK Ziade, N Knitza, J Kuwana, M Cagnotto, G Nune, A Distler, O Chinoy, H Aggarwal, V Aggarwal, R Barman, B Singh, YP Ranjan, R Jain, A Pandya, SC Malaviya, AN Pilania, RK Sharma, A Manoj, MM Gupta, V Kavadichanda, CG Patro, PS Ajmani, S Phatak, S Goswami, RP Chowdhury, AC Mathew, AJ Shenoy, P Asranna, A Bommakanti, KT Shukla, A Naveen, R Cansu, DÜ Pauling, JD Wincup, C Chatterjee, T Kim, M Giannini, M Del Papa, N Sambataro, G Fabiola, A Govoni, M Parisi, S Bocci, EB Sebastiani, GD Fusaro, E Sebastiani, M Quartuccio, L Franceschini, F Sainaghi, PP Orsolini, G De Angelis, R Danielli, MG Traboco, LS Wibowo, SAK Serrano, JR La Torre, IG-D Tehozol, EAZ Loarce-Martos, J Prieto-González, S Gil-Vila, A Aranega, R Nakashima, R Sato, S Kimura, N Kaneko, Y Tomaras, S Gromova, MA Aharonov, O
Copyright, Publisher and Additional Information:	© Crown 2021. Uploaded in accordance with the publisher's self-archiving policy.
Keywords:	COVID-19; Autoimmune diseases; COVAD; Vaccination; Survey
Dates:	Published: January 2022 Published (online): 15 November 2021 Accepted: 28 October 2021
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	26 Nov 2021 11:48
Last Modified:	15 Nov 2022 01:13
Status:	Published
Publisher:	Springer
Identification Number:	10.1007/s00296-021-05046-4
Related URLs:	PubMed URL
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:180878

CORE (COnnecting REpositories)

COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

Abstract

Metadata

Download

Accepted Version

Export

Statistics